FEATURED
Lin Zhou,
Jianxin Xue,
Lei Deng
Frontiers Media SA
Non-small cell lung cancer (NSCLC) is the most common malignancy worldwide, with up to 50% of patients developing brain metastases (BMs) in their disease course. Patients with driver gene mutations...
Health
Oncology
Thoracic Oncology
Keywords: brain metastases,Non-small cell lung cancer,Therapeutic modalities,clinical studies,Molecular mechanisms